FDA Inspection 753076 — Homart Pharmaceuticals Pty. Ltd.

Homart Pharmaceuticals Pty. Ltd. — FEI 2000007615

The FDA completed an inspection of Homart Pharmaceuticals Pty. Ltd. on Nov 4, 2011 in Rydalmere. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 4, 2011
Fiscal Year
2012
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Rydalmere (Australia)

Citations

IDCFRDescription
1547821 CFR 111.20(f)Physical plant - bulbs, fixtures, skylights
1550121 CFR 111.27(a)(3)(i)Equipment - installed to facilitate cleaning
1590221 CFR 111.83(b)(4)Reserve sample - twice the quantity
1597221 CFR 111.120(b)Quality control operations - specifications; components, packaging, labels

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.